期刊文献+

老年患者造影剂肾损害的诊断指标探讨 被引量:4

Diagnostic biomarker of contrast media induced kidney injury in elderly patients
下载PDF
导出
摘要 目的通过对比分析老年患者造影前后血清肌酐(SCr)及血清胱抑素C(CysC)等生物学指标的变化,探讨更适用于老年患者造影剂肾损害的诊断指标。方法收集2010年5月至2011年2月于北京友谊医院医保中心及心内科接受血管造影检查的年龄≥60岁患者的相关资料共41例。用酶法测定入选患者造影前及造影后2h,24h,48h,72hSCr值。留取患者造影前及造影后2h、24h、48h、72h血清及尿液样本,予酶联免疫吸附测定法检测患者血清CysC、中性粒细胞明胶酶相关性载脂蛋白(NGAL)及尿液NGAL、肾损伤分子1(KIM-1)数值,进行造影前后的对比分析。结果依照传统造影剂肾病(CIN)的诊断标准,入选患者中1例发生CIN,患病率为2.44%。依照急性肾损伤网络(AKIN)诊断标准,入选患者中3例发生急性肾损伤,患病率为7.32%。造影后CysC升高≥25%的患者有27例,所占比例为65.9%。CysC水平在造影后24h及48h较造影前水平显著升高,SCr水平在造影前后未见明显改变。造影后CysC升高≥25%患者的血清NGAL、尿NGAL及尿KIM-1造影后的上升幅度明显高于CysC升高〈25%的患者。结论以SCr为指标的传统CIN诊断标准不适合老年患者,CysC可能更加及时、准确地反映老年患者的造影剂肾损害。 Objective To explore the suitable biomarker for timely and accurate diagnosis of contrast media induced kidney injury in elderly patients by comparing the concentration of serum creatinine (SCr), serum cystatin C (CysC)and other biomarkers before and after the angiography. Methods Forty-one old patients aged over 60 years having undergone angiography were enrolled in this study. Before the angiography, 2h, 24h, 48h and 72h after the angiography, the SCr value were tested by enzymic method. The serum and urine sample were also collected to test the serum CysC, serum neutrophil gelatinase-associated lpipocalin (NGAL) and urine kidney injury molecule-1(KIM-1) value with enzyme linked immunosorbent assay (ELISA) method. The levels of the biomarkers from the different time points were compared and analyzed. Results Contrast-induced nephropathy (CIN) occurred in 1 of 41 enrolled patients (2.44%). Acute kidney injury (AKI) occurred in 3 of 41 enrolled patients (7.32%). The concentration of serum CysC increased by over 25% in 27 patients after angiography (65.9%). Before and after angiography, the levels of SCr had no significant change. The levels of serum CysC elevated significantly at 24h and 48h after angiography. Serum NGAL, urine NGAL and urine KIM-1 elevated significantly in the patients with CysC increased by over 25%. Conclusion The traditional diagnostic biomarker of CIN is not suitable for elderly patients. CysC may be a timely and accurate biomarker for the diagnosis of contrast media induced kidney injury in elderly patients.
出处 《中华老年多器官疾病杂志》 2012年第11期837-840,共4页 Chinese Journal of Multiple Organ Diseases in the Elderly
关键词 造影剂肾病 诊断指标 老年人 constrast-induced nephropathy diagnostic biomarker elderly
  • 相关文献

参考文献12

  • 1Tepel M,Aspelin P, Lameire N. Contrast-inducednephropathy: a clinical and evidence-based approach[J].Circulation, 2006,113(14): 1799-1806.
  • 2McCullough P. Outcomes of contrast-induced nephropathy:experience in patients undergoing cardiovascular intervention[J].Catheter Cardiovasc Interv, 2006, 67(3): 335-343.
  • 3周芳芳,罗群.造影剂肾病研究进展[J].中国实用内科杂志,2010,30(9):837-840. 被引量:13
  • 4Poletti PA, Saudan P,Platon A, et al. I.v. N-acetylcysteineand emergency CT: use of serum creatinine and cystatin C asmarkers of radiocontrast nephrotoxicity [J]. AJR Am JRoentgenol, 2007,189(3): 687-692.
  • 5Droppa M,Desch S,Blase P, et al. Impact ofN-acetylcysteine on contrast-induced nephropathy definedby cystatin C in patients with ST-elevation myocardialinfarction undergoing primary angioplastyfJ]. Clin ResCardiol, 2011,100(11): 1037-1043.
  • 6Toprak O. Risk markers for contrast-induced nephropathy [J].Am J Med Sci, 2007, 334(4): 283-290.
  • 7Ultramari FT, Bueno Rda R,da Cunha CL, et al. Contrastmedia-induced nephropathy following diagnostic andtherapeutic cardiac catheterization[J]. Arq Bras Cardiol, 2006,87(3): 378-390.
  • 8Solomon R. Contrast-medium-induced acuterenal failure[J].Kidney Int,1998,53(1): 230-242.
  • 9Briguori C, Visconti Q Rivera NV, et al. Cystatin C andcontrast-induced acute kidney injury [J]. Circulation, 2010,121(19):2117-2122.
  • 10Haase M,Bellomo R, Devarajan P,et al. Accuracy ofneutrophil gelatinase-associated lipocalin (NGAL) indiagnosis and prognosis in acute kidney injury: a systematicreview and meta-analysis[J]. Am J Kidney Dis, 2009, 54(6):1012-1024.

二级参考文献20

  • 1McCullough PA, Adam A, Becker CR, et al. Epidemiology and prognostic implications of contrast-induced nephropathy [J]. Am J Cardiol,2006,98:5K - 13K.
  • 2Subramanian S,Tumlin J, Bapat B, et al. Economic burden of contrast-induced nephropathy: implications for prevention strategies [J]. J Med Econ,2007,10:119 - 134.
  • 3Topark O. Risk Markers for contrast-induced nephropathy[ J]. Am J Med Sci,2007,334(4) :283 -290.
  • 4Probal R, Vikram R, Teruo O, et al. Incidence predictors and outcomes of post-pcrcutaneous coronary intervention nephropathy in patients with diabetes menitus and normal baseline serum creatintine levels[ J]. Am J Cardiol,2008,101 : 1544 - 1549.
  • 5Pannu N, Wiebe N, Tonelli M. Prophylaxis strategies for contrast-induced nephropathy [J]. JAMA, 2006,295 ( 23 ) : 2765 - 2779.
  • 6Toprak O, Cirit M, Yesil M, et al. Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease [ J ]. Nephrol Dial Transplant, 2007,22:819 - 826.
  • 7Ghani AA,Tohamy KY. Risk score for contrast induced nephropathy following percutaneous coronary intervention[J]. Saudi J Kidney Dis Transpl,2009,20 ( 2 ) : 240 - 245.
  • 8Hussain N, Al Otaibi T. Contrast media nephropathy:in depth review [J]. Saudi J Kidney Dis Transpl,2008,19 ( 2 ) : 174 - 182.
  • 9Weisbord SD, Palevsky PM. Prevention of contrast-induced nephropathy with volume expansion [ J ]. Clin J Am Soc Nephrol, 2008,3:273 -280.
  • 10Brar SS, Shen AY, Jorgensen MB, et al. Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial[J]. JAMA,2008,300(9) :1038 - 1046.

共引文献12

同被引文献66

  • 1岳晓军,胡志兵,李婉媚,戴建武,江朝强.老年人慢性心房颤动病因及与脑卒中的关系[J].中西医结合心脑血管病杂志,2005,3(9):813-814. 被引量:5
  • 2孙艺红.心房颤动与脑卒中[J].中华全科医师杂志,2006,5(1):10-11. 被引量:14
  • 3Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency [J]. Am J Kidney Dis, 2002, 39:930-936.
  • 4Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk [J]. Kidney Int Suppl, 2006: S11-5.
  • 5Detrenis S, Meschi M, del Mar Jordana Sanchez M, et al. Con- trast medium induced nephropathy in urological practice [J]. J Urol, 2007, 178(4 Pt 1):1164-1170.
  • 6Tepel M, Aspelin P, Lameire N. Contrast-induced nephropathy: a clinical and evidence-based approach [J]. Circulation, 2006, 113: 1799-1806.
  • 7Dennen P, Parikh CR. Biomarkers of acute kidney injury: can we replace serum creatinine?[J]. Clin Nepbrol, 2007, 68:269-278.
  • 8de Geus HR, Betjes MG, Bakker J. Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges[J]. Clin Kidney J, 2012, 5:102-108.
  • 9Cruz DN, Mehta RL. Acute kidney injury in 2013: Breaking bar- riers for biomarkers in AKI-progress at last [J]. Nat Rev Nephrol, 2014, 10:74-76.
  • 10Alharazy SM, Kong N, Saidin R, et al. Serum neutrophil gelati- nase-associated lipocalin and cystatin C are early biomarkers of contrast-Induced nephropathy after coronary angiography in pa- tients with chronic kidney disease [J]. Angiology, 2013, 65: 436-442.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部